Invesco Nasdaq Biotechnology ETF Price & Performance (IBBQ)

Cathie Wood’s ARK ETFs made notable trades on April 24, selling over 76,000 shares of Adaptive Biotechnologies and increasing their position in Beam Therapeutics. The moves highlight ongoing portfolio shifts in biotech, with ARK continuing to trim Adaptive while showing confidence in Beam’s prospects. Investors often watch ARK’s trades for sector sentiment cues.1

Invesco BulletShares 2027 Corporate Bond ETF has announced a monthly dividend of $0.0681 per share, payable on April 25, 2025. The ex-dividend and record dates were both set for April 21. This payout continues the ETF’s regular income distribution for investors seeking predictable cash flow from fixed-income products.2

Anbio Biotechnology shares rose to $7.10, gaining 3.05% today, with the stock nearing its 52-week high. Despite a recent drop in search activity from India, the stock remains accessible for Indian retail investors, who can purchase fractional shares through digital platforms. Technical analysis places Anbio in a neutral position.3